Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma (SCF980266)
This study has suspended participant recruitment.
(Study closed Nov 2000 by Amgen, who stopped drug delivery)
Sponsor:
Aalborg Universityhospital
Collaborators:
Herlev Hospital
Rigshospitalet, Denmark
Helsinki University Central Hospital
Turku University Hospital
University Hospital, Linkoeping
Umeå University
Radiumhospitalet Oslo Norway
Nordic Lymphoma Group
Amgen
Information provided by:
Aalborg Universityhospital
ClinicalTrials.gov Identifier:
NCT01016795
First received: November 18, 2009
Last updated: November 19, 2009
Last verified: November 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | November 2009 |
| Estimated Primary Completion Date: | November 2000 (Final data collection date for primary outcome measure) |